| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.53e-07 | 81 | 99 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 PLXNA3 LPAR3 GPR17 RAMP3 HTR5A GPR182 ACVR2A SSTR1 PTCH1 GRM3 F2RL2 ADORA2B GPR161 QRFPR NPY4R2 HMCN2 NPY4R OR1E1 LPAR2 TNFRSF1B CHRNA10 | 5.92e-07 | 1353 | 99 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.04e-06 | 37 | 99 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.19e-06 | 38 | 99 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 2.08e-06 | 19 | 99 | 4 | GO:0015373 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.12e-06 | 119 | 99 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 4.44e-06 | 133 | 99 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 6.23e-06 | 140 | 99 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 7.82e-06 | 26 | 99 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | symporter activity | 9.80e-06 | 150 | 99 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.06e-05 | 28 | 99 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.90e-05 | 11 | 99 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 1.90e-05 | 11 | 99 | 3 | GO:0004983 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.29e-05 | 171 | 99 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 2.35e-05 | 34 | 99 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.37e-05 | 69 | 99 | 5 | GO:0005504 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 2.52e-05 | 12 | 99 | 3 | GO:0008504 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.65e-05 | 35 | 99 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | LPAR3 GPR17 RAMP3 HTR5A GPR182 SSTR1 GRM3 F2RL2 ADORA2B GPR161 QRFPR NPY4R2 NPY4R OR1E1 LPAR2 | 2.91e-05 | 884 | 99 | 15 | GO:0004930 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.14e-05 | 14 | 99 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | steroid binding | 5.26e-05 | 133 | 99 | 6 | GO:0005496 | |
| GeneOntologyMolecularFunction | serotonin:sodium:chloride symporter activity | 7.28e-05 | 3 | 99 | 2 | GO:0005335 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 7.64e-05 | 17 | 99 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 7.91e-05 | 46 | 99 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | retinoid binding | 9.36e-05 | 48 | 99 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.01e-04 | 49 | 99 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.06e-04 | 151 | 99 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.38e-04 | 53 | 99 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | monoamine:proton antiporter activity | 1.45e-04 | 4 | 99 | 2 | GO:0015311 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 1.45e-04 | 4 | 99 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | adrenomedullin receptor activity | 1.45e-04 | 4 | 99 | 2 | GO:0001605 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.47e-04 | 21 | 99 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.93e-04 | 107 | 99 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.95e-04 | 23 | 99 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | beta-galactosidase activity | 2.41e-04 | 5 | 99 | 2 | GO:0004565 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 2.41e-04 | 5 | 99 | 2 | GO:0070915 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 2.51e-04 | 25 | 99 | 3 | GO:0005243 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 3.24e-04 | 66 | 99 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | eukaryotic translation initiation factor 2alpha kinase activity | 3.60e-04 | 6 | 99 | 2 | GO:0004694 | |
| GeneOntologyMolecularFunction | calcitonin family receptor activity | 5.03e-04 | 7 | 99 | 2 | GO:0097642 | |
| GeneOntologyMolecularFunction | galactosidase activity | 5.03e-04 | 7 | 99 | 2 | GO:0015925 | |
| GeneOntologyMolecularFunction | transporter activity | NPC1 SLC17A3 GJB6 PIEZO1 SLC1A6 SLC5A5 GJA9 SLC6A12 GJB1 SLC18A1 SLC18A2 CHRNA10 SLC23A1 SLC29A4 SLC38A8 SLC23A3 | 5.79e-04 | 1289 | 99 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 6.82e-04 | 296 | 99 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC17A3 GJB6 PIEZO1 SLC1A6 SLC5A5 GJA9 SLC6A12 GJB1 SLC18A1 SLC18A2 CHRNA10 SLC23A1 SLC29A4 SLC38A8 SLC23A3 | 6.85e-04 | 1180 | 99 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 6.90e-04 | 35 | 99 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 7.52e-04 | 301 | 99 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 8.13e-04 | 37 | 99 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 8.13e-04 | 37 | 99 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 8.13e-04 | 37 | 99 | 3 | GO:0022829 | |
| GeneOntologyMolecularFunction | urate transmembrane transporter activity | 8.56e-04 | 9 | 99 | 2 | GO:0015143 | |
| GeneOntologyMolecularFunction | salt transmembrane transporter activity | 8.56e-04 | 9 | 99 | 2 | GO:1901702 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.79e-04 | 38 | 99 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 8.79e-04 | 38 | 99 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 9.63e-04 | 152 | 99 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.22e-03 | 239 | 99 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 1.55e-03 | 12 | 99 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.62e-03 | 171 | 99 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.67e-03 | 254 | 99 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC17A3 PIEZO1 SLC1A6 SLC5A5 SLC6A12 SLC18A1 SLC18A2 CHRNA10 SLC23A1 SLC29A4 | 1.68e-03 | 664 | 99 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC17A3 SLC1A6 SLC5A5 SLC6A12 SLC18A1 SLC18A2 CHRNA10 SLC23A1 | 2.19e-03 | 465 | 99 | 8 | GO:0046873 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC17A3 SLC1A6 SLC5A5 SLC6A12 SLC18A1 SLC18A2 SLC23A1 SLC29A4 | 2.57e-03 | 477 | 99 | 8 | GO:0022804 |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 2.79e-03 | 16 | 99 | 2 | GO:0015562 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 2.79e-03 | 16 | 99 | 2 | GO:0045125 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.83e-03 | 118 | 99 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | lipid binding | NPC1 LPAR3 UGT1A10 UGT1A8 UGT1A7 UGT1A9 PTCH1 DYSF MAP3K1 GSTA3 CLN6 LPAR2 | 3.53e-03 | 988 | 99 | 12 | GO:0008289 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.79e-03 | 208 | 99 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 4.02e-03 | 211 | 99 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 4.70e-03 | 136 | 99 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 4.70e-03 | 136 | 99 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 5.57e-03 | 430 | 99 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 5.75e-03 | 23 | 99 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | nuclease activity | 5.88e-03 | 231 | 99 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC17A3 PIEZO1 SLC1A6 SLC5A5 SLC6A12 SLC18A1 SLC18A2 CHRNA10 SLC23A1 SLC29A4 | 5.95e-03 | 793 | 99 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 7.11e-03 | 153 | 99 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 7.12e-03 | 79 | 99 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | ERVK-6 MYO9B UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTA3 SLC5A5 CLN6 G6PD | 7.16e-03 | 815 | 99 | 10 | GO:0042803 |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 9.05e-03 | 29 | 99 | 2 | GO:0005416 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 2.39e-09 | 5 | 98 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 7.13e-09 | 6 | 98 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 7.13e-09 | 6 | 98 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 7.13e-09 | 6 | 98 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 9.84e-08 | 10 | 98 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 9.84e-08 | 10 | 98 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 3.32e-07 | 13 | 98 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.03e-06 | 5 | 98 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.70e-06 | 21 | 98 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 2.70e-06 | 21 | 98 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 4.76e-06 | 52 | 98 | 5 | GO:0001504 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 6.61e-06 | 26 | 98 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 6.61e-06 | 26 | 98 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.67e-05 | 67 | 98 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.99e-05 | 34 | 98 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.22e-05 | 12 | 98 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.87e-05 | 13 | 98 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 3.12e-05 | 38 | 98 | 4 | GO:0098810 | |
| GeneOntologyBiologicalProcess | serotonin uptake | 3.64e-05 | 14 | 98 | 3 | GO:0051610 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.09e-04 | 52 | 98 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | histamine uptake | 1.33e-04 | 4 | 98 | 2 | GO:0051615 | |
| GeneOntologyBiologicalProcess | aminergic neurotransmitter loading into synaptic vesicle | 1.33e-04 | 4 | 98 | 2 | GO:0015842 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 2.45e-04 | 64 | 98 | 4 | GO:0042908 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3.03e-04 | 191 | 98 | 6 | GO:0007189 | |
| GeneOntologyBiologicalProcess | liver development | 4.08e-04 | 202 | 98 | 6 | GO:0001889 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 4.28e-04 | 376 | 98 | 8 | GO:0008202 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 4.32e-04 | 286 | 98 | 7 | GO:0007188 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 4.41e-04 | 205 | 98 | 6 | GO:0061008 | |
| GeneOntologyBiologicalProcess | serotonin transport | 4.67e-04 | 32 | 98 | 3 | GO:0006837 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 5.67e-04 | 141 | 98 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 6.71e-04 | 222 | 98 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 7.19e-04 | 37 | 98 | 3 | GO:0034656 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 7.23e-04 | 85 | 98 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 7.23e-04 | 85 | 98 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 7.78e-04 | 38 | 98 | 3 | GO:0015874 | |
| GeneOntologyBiologicalProcess | norepinephrine uptake | 7.87e-04 | 9 | 98 | 2 | GO:0051620 | |
| GeneOntologyBiologicalProcess | syncytium formation | 8.59e-04 | 89 | 98 | 4 | GO:0006949 | |
| GeneOntologyCellularComponent | connexin complex | 1.53e-04 | 22 | 100 | 3 | GO:0005922 | |
| GeneOntologyCellularComponent | clathrin-sculpted monoamine transport vesicle | 2.24e-04 | 5 | 100 | 2 | GO:0070081 | |
| GeneOntologyCellularComponent | clathrin-sculpted monoamine transport vesicle membrane | 2.24e-04 | 5 | 100 | 2 | GO:0070083 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ILDR2 UBE2J1 CDS1 SLC17A3 UGT1A10 UGT1A8 UGT1A7 PIEZO1 UGT1A9 POMT1 PAPPA-AS1 GJB1 SLC18A1 CNEP1R1 CLN6 TRAF3IP3 | 5.42e-04 | 1327 | 100 | 16 | GO:0042175 |
| GeneOntologyCellularComponent | gap junction | 7.33e-04 | 37 | 100 | 3 | GO:0005921 | |
| GeneOntologyCellularComponent | axon | LPAR3 MYO9A PTCH1 GRM3 HMCN2 SLC18A1 SLC18A2 AP3B2 TNFRSF1B CHRNA10 DYNC1H1 SLC38A8 | 1.12e-03 | 891 | 100 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ILDR2 UBE2J1 CDS1 SLC17A3 UGT1A10 UGT1A8 UGT1A7 PIEZO1 UGT1A9 POMT1 PAPPA-AS1 GJB1 SLC18A1 CLN6 TRAF3IP3 | 1.21e-03 | 1293 | 100 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ILDR2 UBE2J1 CDS1 SLC17A3 UGT1A10 UGT1A8 UGT1A7 PIEZO1 UGT1A9 POMT1 PAPPA-AS1 GJB1 SLC18A1 CLN6 TRAF3IP3 | 1.27e-03 | 1299 | 100 | 15 | GO:0098827 |
| Domain | UDPGT | 2.96e-06 | 21 | 91 | 4 | PF00201 | |
| Domain | UDPGT | 2.96e-06 | 21 | 91 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 2.96e-06 | 21 | 91 | 4 | IPR002213 | |
| Domain | NPY_rcpt | 9.20e-06 | 9 | 91 | 3 | IPR000611 | |
| Domain | GPCR_Rhodpsn_7TM | LPAR3 GPR17 HTR5A GPR182 SSTR1 F2RL2 ADORA2B GPR161 QRFPR NPY4R2 NPY4R OR1E1 LPAR2 | 2.12e-05 | 670 | 91 | 13 | IPR017452 |
| Domain | NPY4_rcpt | 2.35e-05 | 2 | 91 | 2 | IPR001933 | |
| Domain | 7tm_1 | LPAR3 GPR17 HTR5A GPR182 SSTR1 F2RL2 ADORA2B GPR161 QRFPR NPY4R2 NPY4R OR1E1 LPAR2 | 2.36e-05 | 677 | 91 | 13 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | LPAR3 GPR17 HTR5A GPR182 SSTR1 F2RL2 ADORA2B GPR161 QRFPR NPY4R2 NPY4R OR1E1 LPAR2 | 2.67e-05 | 685 | 91 | 13 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | LPAR3 GPR17 HTR5A GPR182 SSTR1 F2RL2 ADORA2B GPR161 QRFPR NPY4R2 NPY4R OR1E1 LPAR2 | 2.92e-05 | 691 | 91 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | LPAR3 GPR17 HTR5A GPR182 SSTR1 F2RL2 ADORA2B GPR161 QRFPR NPY4R2 NPY4R OR1E1 LPAR2 | 2.97e-05 | 692 | 91 | 13 | IPR000276 |
| Domain | Xan_ur_permease | 7.02e-05 | 3 | 91 | 2 | PF00860 | |
| Domain | Xant/urac/vitC | 7.02e-05 | 3 | 91 | 2 | IPR006043 | |
| Domain | LPA_rcpt | 7.02e-05 | 3 | 91 | 2 | IPR004065 | |
| Domain | CONNEXINS_1 | 1.02e-04 | 19 | 91 | 3 | PS00407 | |
| Domain | CONNEXINS_2 | 1.20e-04 | 20 | 91 | 3 | PS00408 | |
| Domain | Connexin | 1.20e-04 | 20 | 91 | 3 | IPR000500 | |
| Domain | Connexin_CCC | 1.20e-04 | 20 | 91 | 3 | IPR019570 | |
| Domain | Connexin_N | 1.20e-04 | 20 | 91 | 3 | IPR013092 | |
| Domain | Connexin | 1.20e-04 | 20 | 91 | 3 | PF00029 | |
| Domain | Connexin_CCC | 1.20e-04 | 20 | 91 | 3 | SM01089 | |
| Domain | Connexin_CS | 1.20e-04 | 20 | 91 | 3 | IPR017990 | |
| Domain | CNX | 1.20e-04 | 20 | 91 | 3 | SM00037 | |
| Domain | Glyco_hydro_35 | 1.40e-04 | 4 | 91 | 2 | PF01301 | |
| Domain | Gly_Hdrlase_35_cat | 1.40e-04 | 4 | 91 | 2 | IPR031330 | |
| Domain | Glycoside_Hdrlase_35 | 1.40e-04 | 4 | 91 | 2 | IPR001944 | |
| Domain | B-gal_1-like | 1.40e-04 | 4 | 91 | 2 | IPR026283 | |
| Domain | GLYCOSYL_HYDROL_F35 | 1.40e-04 | 4 | 91 | 2 | PS01182 | |
| Domain | Ptc/Disp | 8.27e-04 | 9 | 91 | 2 | IPR003392 | |
| Domain | Patched | 8.27e-04 | 9 | 91 | 2 | PF02460 | |
| Domain | Myosin_head_motor_dom | 8.34e-04 | 38 | 91 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 8.34e-04 | 38 | 91 | 3 | PS51456 | |
| Domain | Myosin_head | 8.34e-04 | 38 | 91 | 3 | PF00063 | |
| Domain | MYSc | 8.34e-04 | 38 | 91 | 3 | SM00242 | |
| Domain | SSD | 1.77e-03 | 13 | 91 | 2 | IPR000731 | |
| Domain | SSD | 1.77e-03 | 13 | 91 | 2 | PS50156 | |
| Domain | 7TM_GPCR_Srsx | 2.19e-03 | 112 | 91 | 4 | SM01381 | |
| Domain | MFS_dom | 4.18e-03 | 134 | 91 | 4 | IPR020846 | |
| Domain | IQ | 5.04e-03 | 71 | 91 | 3 | PF00612 | |
| Domain | MFS_1 | 6.31e-03 | 77 | 91 | 3 | PF07690 | |
| Domain | MFS | 6.31e-03 | 77 | 91 | 3 | IPR011701 | |
| Domain | IQ | 7.26e-03 | 81 | 91 | 3 | SM00015 | |
| Pathway | WP_ESTROGEN_METABOLISM | 7.97e-08 | 22 | 73 | 5 | MM15888 | |
| Pathway | WP_GPCRS_NONODORANT | LPAR3 GPR17 HTR5A SSTR1 GRM3 F2RL2 ADORA2B QRFPR NPY4R LPAR2 | 1.06e-06 | 266 | 73 | 10 | MM15843 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | LPAR3 GPR17 RAMP3 HTR5A SSTR1 PTCH1 GRM3 F2RL2 ADORA2B QRFPR NPY4R LPAR2 | 4.07e-06 | 463 | 73 | 12 | M507 |
| Pathway | REACTOME_GLUCURONIDATION | 6.50e-06 | 24 | 73 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.71e-06 | 25 | 73 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 7.71e-06 | 25 | 73 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 7.71e-06 | 25 | 73 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 9.08e-06 | 26 | 73 | 4 | M39404 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.07e-05 | 272 | 73 | 9 | M13380 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | LPAR3 GPR17 RAMP3 HTR5A SSTR1 GRM3 F2RL2 ADORA2B QRFPR NPY4R LPAR2 | 1.21e-05 | 430 | 73 | 11 | MM15160 |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.23e-05 | 28 | 73 | 4 | M19580 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.02e-05 | 70 | 73 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.46e-05 | 72 | 73 | 5 | M9257 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 4.65e-05 | 14 | 73 | 3 | M39328 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.75e-05 | 39 | 73 | 4 | MM15695 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.92e-05 | 330 | 73 | 9 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 5.28e-05 | 333 | 73 | 9 | MM14963 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 5.74e-05 | 260 | 73 | 8 | M39397 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 5.80e-05 | 41 | 73 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.40e-05 | 45 | 73 | 4 | MM15694 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.22e-04 | 19 | 73 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.22e-04 | 19 | 73 | 3 | MM15107 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.38e-04 | 51 | 73 | 4 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.48e-04 | 52 | 73 | 4 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.85e-04 | 55 | 73 | 4 | M14933 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.29e-04 | 107 | 73 | 5 | MM14595 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | LPAR3 GPR17 RAMP3 HTR5A SSTR1 PTCH1 GRM3 F2RL2 ADORA2B QRFPR NPY4R LPAR2 | 2.37e-04 | 702 | 73 | 12 | M746 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.49e-04 | 109 | 73 | 5 | M18788 | |
| Pathway | KEGG_RETINOL_METABOLISM | 3.32e-04 | 64 | 73 | 4 | M9488 | |
| Pathway | REACTOME_DRUG_ADME | 3.74e-04 | 119 | 73 | 5 | MM15692 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | LPAR3 GPR17 RAMP3 HTR5A SSTR1 GRM3 F2RL2 ADORA2B QRFPR NPY4R LPAR2 | 4.59e-04 | 646 | 73 | 11 | MM14962 |
| Pathway | WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS | 7.26e-04 | 8 | 73 | 2 | M42529 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 7.26e-04 | 289 | 73 | 7 | MM15057 | |
| Pathway | WP_NRF2_PATHWAY | 8.12e-04 | 141 | 73 | 5 | M39454 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 9.30e-04 | 9 | 73 | 2 | MM1477 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY | 9.30e-04 | 9 | 73 | 2 | M47732 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 9.87e-04 | 38 | 73 | 3 | M14981 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.17e-03 | 153 | 73 | 5 | MM15844 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.18e-03 | 314 | 73 | 7 | M600 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 1.41e-03 | 11 | 73 | 2 | M17668 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.44e-03 | 238 | 73 | 6 | MM15076 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.52e-03 | 44 | 73 | 3 | M45014 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.69e-03 | 12 | 73 | 2 | M39611 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.81e-03 | 249 | 73 | 6 | M5988 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 1.99e-03 | 13 | 73 | 2 | M47731 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 2.31e-03 | 14 | 73 | 2 | M27331 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 2.31e-03 | 14 | 73 | 2 | MM15062 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.32e-03 | 51 | 73 | 3 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.32e-03 | 51 | 73 | 3 | MM14499 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.32e-03 | 51 | 73 | 3 | M26972 | |
| Pathway | REACTOME_DRUG_ADME | 2.44e-03 | 109 | 73 | 4 | M45012 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 2.66e-03 | 15 | 73 | 2 | M691 | |
| Pathway | REACTOME_PENTOSE_PHOSPHATE_PATHWAY | 2.66e-03 | 15 | 73 | 2 | M27682 | |
| Pathway | REACTOME_PENTOSE_PHOSPHATE_PATHWAY | 2.66e-03 | 15 | 73 | 2 | MM15404 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 2.66e-03 | 15 | 73 | 2 | MM14799 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.76e-03 | 186 | 73 | 5 | MM15994 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 3.03e-03 | 16 | 73 | 2 | MM15050 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 3.03e-03 | 16 | 73 | 2 | M6786 | |
| Pubmed | 1.38e-10 | 12 | 100 | 5 | 19419973 | ||
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.24e-10 | 13 | 100 | 5 | 25246029 | |
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 32527940 | ||
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 2.24e-09 | 7 | 100 | 4 | 8467709 | |
| Pubmed | 2.24e-09 | 7 | 100 | 4 | 8464825 | ||
| Pubmed | 2.24e-09 | 7 | 100 | 4 | 27514509 | ||
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 17179145 | ||
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 20610558 | ||
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 18052087 | ||
| Pubmed | 8.02e-09 | 9 | 100 | 4 | 22511988 | ||
| Pubmed | 1.33e-08 | 10 | 100 | 4 | 23642732 | ||
| Pubmed | 1.33e-08 | 10 | 100 | 4 | 11465080 | ||
| Pubmed | 1.33e-08 | 10 | 100 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.33e-08 | 10 | 100 | 4 | 22558097 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 29519853 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 12847094 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 3.13e-08 | 12 | 100 | 4 | 20308471 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 3.13e-08 | 12 | 100 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 4.51e-08 | 13 | 100 | 4 | 22085899 | |
| Pubmed | 6.30e-08 | 14 | 100 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 6.30e-08 | 14 | 100 | 4 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 6.30e-08 | 14 | 100 | 4 | 14672974 | |
| Pubmed | 6.30e-08 | 14 | 100 | 4 | 9295054 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.14e-07 | 16 | 100 | 4 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.49e-07 | 17 | 100 | 4 | 20639394 | |
| Pubmed | 1.91e-07 | 18 | 100 | 4 | 20056724 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.30e-07 | 5 | 100 | 3 | 12629516 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 20565459 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 15057901 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 2.41e-07 | 19 | 100 | 4 | 23281178 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 6.54e-07 | 24 | 100 | 4 | 24625756 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 11212352 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 1.23e-06 | 118 | 100 | 6 | 19156168 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 1.91e-06 | 9 | 100 | 3 | 20732626 | |
| Pubmed | 2.61e-06 | 75 | 100 | 5 | 2834384 | ||
| Pubmed | 3.74e-06 | 11 | 100 | 3 | 18695635 | ||
| Pubmed | 4.98e-06 | 12 | 100 | 3 | 14557543 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 7.96e-06 | 94 | 100 | 5 | 21542922 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25463482 | ||
| Pubmed | Lysophosphatidic acid receptors 2 and 3 regulate erythropoiesis at different hematopoietic stages. | 8.18e-06 | 2 | 100 | 2 | 33035680 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12871984 | ||
| Pubmed | Lysosome lipid storage disorder in NCTR-BALB/c mice. I. Description of the disease and genetics. | 8.18e-06 | 2 | 100 | 2 | 6765731 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32451867 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25547628 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32006610 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33406026 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 8.18e-06 | 2 | 100 | 2 | 9460924 | |
| Pubmed | Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis. | 8.18e-06 | 2 | 100 | 2 | 27244685 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11901093 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19756140 | ||
| Pubmed | Chromosomal localization of the human vesicular amine transporter genes. | 8.18e-06 | 2 | 100 | 2 | 7905859 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11677206 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22031623 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 8.18e-06 | 2 | 100 | 2 | 10497143 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 8.18e-06 | 2 | 100 | 2 | 17603215 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15709193 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12944498 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11431013 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26338179 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35524772 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8643547 | ||
| Pubmed | Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. | 8.18e-06 | 2 | 100 | 2 | 19001604 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9647757 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17529886 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20089735 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33347862 | ||
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 8022818 | ||
| Pubmed | 1.14e-05 | 48 | 100 | 4 | 8884266 | ||
| Pubmed | 1.91e-05 | 190 | 100 | 6 | 24816252 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 2.26e-05 | 57 | 100 | 4 | 21886157 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19364970 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 2.45e-05 | 3 | 100 | 2 | 20007669 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23721685 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19244109 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10516026 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 26247833 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 16189177 | ||
| Pubmed | Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor. | 2.45e-05 | 3 | 100 | 2 | 23569130 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 17339869 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 12123830 | ||
| Pubmed | Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling. | 2.45e-05 | 3 | 100 | 2 | 18448840 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 12827358 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 2.45e-05 | 3 | 100 | 2 | 24453052 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19225446 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23789755 | ||
| Pubmed | Connexin43, but not connexin30, contributes to adult neurogenesis in the dentate gyrus. | 2.45e-05 | 3 | 100 | 2 | 28689039 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19899077 | ||
| Pubmed | Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells. | 2.45e-05 | 3 | 100 | 2 | 21964883 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 17406868 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22098503 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23637189 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 11093753 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19996319 | ||
| Pubmed | LPA receptor expression in the central nervous system in health and following injury. | 2.45e-05 | 3 | 100 | 2 | 20495828 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 16397224 | ||
| Interaction | UGT1A7 interactions | 2.46e-07 | 57 | 93 | 6 | int:UGT1A7 | |
| Interaction | ALDH3B2 interactions | 4.99e-06 | 25 | 93 | 4 | int:ALDH3B2 | |
| Interaction | PIGG interactions | 9.11e-06 | 61 | 93 | 5 | int:PIGG | |
| Interaction | LRP10 interactions | 1.54e-05 | 115 | 93 | 6 | int:LRP10 | |
| Interaction | YIPF3 interactions | 2.47e-05 | 186 | 93 | 7 | int:YIPF3 | |
| Interaction | UGT1A9 interactions | 2.63e-05 | 13 | 93 | 3 | int:UGT1A9 | |
| Interaction | UGT1A8 interactions | 6.30e-05 | 3 | 93 | 2 | int:UGT1A8 | |
| Interaction | ABHD12 interactions | 7.84e-05 | 95 | 93 | 5 | int:ABHD12 | |
| Interaction | ATP2A3 interactions | 1.00e-04 | 232 | 93 | 7 | int:ATP2A3 | |
| Cytoband | 2q37 | 6.12e-07 | 31 | 99 | 4 | 2q37 | |
| Cytoband | 11q25 | 1.45e-03 | 26 | 99 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.49e-03 | 226 | 99 | 4 | chr2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q25 | 2.06e-03 | 31 | 99 | 2 | chr11q25 | |
| GeneFamily | Solute carriers | SLC17A3 SLC1A6 SLC35F5 SLC5A5 SLC6A12 SLC18A1 SLC18A2 SLC23A1 SLC29A4 SLC38A8 SLC23A3 | 6.18e-08 | 395 | 60 | 11 | 752 |
| GeneFamily | UDP glucuronosyltransferases | 3.68e-06 | 32 | 60 | 4 | 363 | |
| GeneFamily | Myosins, class IX | 1.08e-05 | 2 | 60 | 2 | 1103 | |
| GeneFamily | Gap junction proteins | 5.12e-05 | 22 | 60 | 3 | 314 | |
| GeneFamily | Lysophosphatidic acid receptors | 1.61e-04 | 6 | 60 | 2 | 205 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 2.21e-03 | 78 | 60 | 3 | 262 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#5_top-relative-expression-ranked_200 | 3.12e-05 | 42 | 91 | 4 | gudmap_developingKidney_e15.5_Proximal Tubules_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#1_top-relative-expression-ranked_200 | 3.76e-05 | 44 | 91 | 4 | gudmap_developingKidney_e15.5_early proxim tubul_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_200 | 4.74e-05 | 151 | 91 | 6 | gudmap_developingKidney_e15.5_early proxim tubul_200 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.55e-07 | 187 | 95 | 7 | 03de3c2df31bca0dc4e3718bada708d8fe8b69b9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 162 | 95 | 6 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 168 | 95 | 6 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.48e-06 | 200 | 95 | 6 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.35e-05 | 142 | 95 | 5 | 6a656d28c9f5dfb03a3a2d908cf2edbe0a5b1206 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.35e-05 | 142 | 95 | 5 | 671ba8869db7a6dc69fd1caf0e561f15a312b170 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.35e-05 | 142 | 95 | 5 | 3557084150670fd2e2634fc674f228ab85181b59 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.35e-05 | 142 | 95 | 5 | a3d1f4b570b75402171e38c5a7c88e2896520c8f | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 144 | 95 | 5 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 1.81e-05 | 151 | 95 | 5 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 157 | 95 | 5 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 157 | 95 | 5 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 167 | 95 | 5 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 169 | 95 | 5 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 172 | 95 | 5 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | IIH-CD8-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 3.47e-05 | 173 | 95 | 5 | 4f2843371d18af766c1892529ce286f56c956fde | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 175 | 95 | 5 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 175 | 95 | 5 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 92 | 95 | 4 | 246aebf5f17d50f67a7b48f713ea5043cefefb24 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 184 | 95 | 5 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-05 | 184 | 95 | 5 | 3b0389c3a5a16697de860e98ebc48ed39ede646f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-05 | 93 | 95 | 4 | 93a8d3ad978e4cd450f7a69a4cbac1a59038e80d | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.16e-05 | 188 | 95 | 5 | b294d6658e79328bd6fa33223e8c70117ba9789b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 189 | 95 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-05 | 190 | 95 | 5 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 97 | 95 | 4 | 440d45ecfc9b66cb61d734118601e745892d51e3 | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 97 | 95 | 4 | 6fff45d4c4bbd81a67e1ad12b131cfe6a5ab37e6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 191 | 95 | 5 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 191 | 95 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 192 | 95 | 5 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 193 | 95 | 5 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 194 | 95 | 5 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 194 | 95 | 5 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 194 | 95 | 5 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 195 | 95 | 5 | 54fde2cfa51ab3a2d48d2426494ca6f0ce77f725 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.29e-05 | 196 | 95 | 5 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.29e-05 | 196 | 95 | 5 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.29e-05 | 196 | 95 | 5 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.29e-05 | 196 | 95 | 5 | 81278e696d823744267d6315c4d42799c4ea0b2c | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 6.44e-05 | 197 | 95 | 5 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.44e-05 | 197 | 95 | 5 | 88859b7b24b36afab4a684fd7abf0e0f8e5b525c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-05 | 197 | 95 | 5 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.44e-05 | 197 | 95 | 5 | e817c1a8549e403e723b1b6c73cdb04f1179909d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Cilia-bearing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.75e-05 | 199 | 95 | 5 | 2d8ab4aee300c7c4baf662940ce855da2b6d2cae | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.75e-05 | 199 | 95 | 5 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.92e-05 | 200 | 95 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.92e-05 | 200 | 95 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_only / Treatment groups by lineage, cell group, cell type | 6.92e-05 | 200 | 95 | 5 | afbbfe0b8e66df36c244935182cb26feeb31a085 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.92e-05 | 200 | 95 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.03e-05 | 103 | 95 | 4 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-2|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.30e-05 | 104 | 95 | 4 | 57d2a707aacaa90f92895b87f4ecf87b7451d667 | |
| Drug | naringenin chalcone | 1.36e-09 | 5 | 94 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 1.36e-09 | 5 | 94 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 4.06e-09 | 6 | 94 | 4 | ctd:C543211 | |
| Drug | alloin | 4.06e-09 | 6 | 94 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 4.06e-09 | 6 | 94 | 4 | ctd:C107497 | |
| Drug | bevirimat | 7.43e-09 | 36 | 94 | 6 | CID000457928 | |
| Drug | 2',4'-dihydroxychalcone | 9.44e-09 | 7 | 94 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 1.88e-08 | 8 | 94 | 4 | ctd:C034890 | |
| Drug | AC1MRQNQ | 3.38e-08 | 9 | 94 | 4 | CID003522271 | |
| Drug | DHPASiU | 3.38e-08 | 9 | 94 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 3.38e-08 | 9 | 94 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 3.38e-08 | 9 | 94 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 3.38e-08 | 9 | 94 | 4 | CID005460873 | |
| Drug | 2,6-dihydroxyanthraquinone | 5.61e-08 | 10 | 94 | 4 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 8.79e-08 | 11 | 94 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 8.79e-08 | 11 | 94 | 4 | CID006442661 | |
| Drug | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 1.18e-07 | 29 | 94 | 5 | ctd:C060533 | |
| Drug | N-OH-DABZ | 1.31e-07 | 12 | 94 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.31e-07 | 12 | 94 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 1.31e-07 | 12 | 94 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 1.31e-07 | 12 | 94 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 1.31e-07 | 12 | 94 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.31e-07 | 12 | 94 | 4 | CID000276709 | |
| Drug | paricalcitol | 1.41e-07 | 30 | 94 | 5 | CID005281104 | |
| Drug | 4-ethylphenol | 1.68e-07 | 31 | 94 | 5 | CID000031242 | |
| Drug | 2-hydroxyestrone | 1.89e-07 | 13 | 94 | 4 | ctd:C024980 | |
| Drug | tritanol | 1.89e-07 | 13 | 94 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.89e-07 | 13 | 94 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.89e-07 | 13 | 94 | 4 | CID000000411 | |
| Drug | alizarin | 1.89e-07 | 13 | 94 | 4 | ctd:C010078 | |
| Drug | R(-)-Denopamine | 2.33e-07 | 33 | 94 | 5 | CID000003818 | |
| Drug | arabinosyluracil | ERVK-6 GALT UGT1A10 UGT1A8 UGT1A7 UGT1A9 PRPF8 DERA ADORA2B APOBEC2 SLC29A4 | 2.40e-07 | 354 | 94 | 11 | CID000001177 |
| Drug | propranolol glucuronide | 2.64e-07 | 14 | 94 | 4 | CID000119515 | |
| Drug | PCB-61 | 2.64e-07 | 14 | 94 | 4 | CID000036401 | |
| Drug | hydratropic acid | 2.72e-07 | 4 | 94 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 2.72e-07 | 4 | 94 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 2.72e-07 | 4 | 94 | 3 | ctd:C037760 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 3.59e-07 | 15 | 94 | 4 | CID000040469 | |
| Drug | afloqualone | 3.59e-07 | 15 | 94 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 3.59e-07 | 15 | 94 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 3.59e-07 | 15 | 94 | 4 | CID000010752 | |
| Drug | bergamottin | 3.59e-07 | 15 | 94 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 3.59e-07 | 15 | 94 | 4 | CID000543743 | |
| Drug | glucoraphanin | 3.67e-07 | 36 | 94 | 5 | CID000656556 | |
| Drug | AC1L9DGV | 3.67e-07 | 36 | 94 | 5 | CID000417381 | |
| Drug | quercetin-3,4'-diglucoside | 4.77e-07 | 16 | 94 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 4.77e-07 | 16 | 94 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 4.77e-07 | 16 | 94 | 4 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 6.22e-07 | 17 | 94 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 6.22e-07 | 17 | 94 | 4 | CID000037766 | |
| Drug | atazanavir | 6.64e-07 | 120 | 94 | 7 | CID000148192 | |
| Drug | isovaleric acid | 6.77e-07 | 5 | 94 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 6.77e-07 | 5 | 94 | 3 | ctd:C012776 | |
| Drug | SureCN12722713 | 7.97e-07 | 18 | 94 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 7.97e-07 | 18 | 94 | 4 | CID000152226 | |
| Drug | Br 2 | 7.97e-07 | 18 | 94 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 7.97e-07 | 18 | 94 | 4 | CID000036614 | |
| Drug | ApApG | 7.97e-07 | 18 | 94 | 4 | CID003081975 | |
| Drug | C1 11-32 | 7.97e-07 | 18 | 94 | 4 | CID000443077 | |
| Drug | C11131 | 7.97e-07 | 18 | 94 | 4 | CID000443076 | |
| Drug | AC1NFJIQ | 8.12e-07 | 42 | 94 | 5 | CID004659568 | |
| Drug | 9-OH-risperidone | 1.01e-06 | 19 | 94 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.01e-06 | 19 | 94 | 4 | CID000091433 | |
| Drug | almokalant | 1.01e-06 | 19 | 94 | 4 | CID003033962 | |
| Drug | MS-222 | 1.03e-06 | 44 | 94 | 5 | CID000011400 | |
| Drug | tectochrysin | 1.25e-06 | 20 | 94 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 1.25e-06 | 20 | 94 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.25e-06 | 20 | 94 | 4 | CID000116545 | |
| Drug | entacapone | 1.25e-06 | 20 | 94 | 4 | ctd:C071192 | |
| Drug | 3-phenylpropionic acid | 1.35e-06 | 6 | 94 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 1.35e-06 | 6 | 94 | 3 | ctd:D007216 | |
| Drug | estriol-16-glucuronide | 1.55e-06 | 21 | 94 | 4 | CID000122281 | |
| Drug | dulcin | 1.55e-06 | 21 | 94 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.55e-06 | 21 | 94 | 4 | CID000069186 | |
| Drug | salicylamide | 1.60e-06 | 48 | 94 | 5 | CID000005147 | |
| Drug | retigabine | 1.60e-06 | 48 | 94 | 5 | CID000121892 | |
| Drug | amitriptyline | 1.87e-06 | 140 | 94 | 7 | CID000002160 | |
| Drug | amonafide | 1.88e-06 | 22 | 94 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 1.88e-06 | 22 | 94 | 4 | CID000053167 | |
| Drug | plumbagin | 1.88e-06 | 22 | 94 | 4 | ctd:C014758 | |
| Drug | phenanthroline | 1.97e-06 | 50 | 94 | 5 | CID000067473 | |
| Drug | (+/-)-Abacavir | 2.18e-06 | 51 | 94 | 5 | CID000001971 | |
| Drug | H944 | 2.26e-06 | 92 | 94 | 6 | CID000004271 | |
| Drug | amidoxime | 2.27e-06 | 23 | 94 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 2.27e-06 | 23 | 94 | 4 | CID000066651 | |
| Drug | phenanthridine | 2.27e-06 | 23 | 94 | 4 | CID000009189 | |
| Drug | AC1Q5UBL | 2.48e-06 | 146 | 94 | 7 | CID000005466 | |
| Drug | AS-3201 | 2.72e-06 | 24 | 94 | 4 | CID000153948 | |
| Drug | 5-MOP | 3.22e-06 | 25 | 94 | 4 | CID000002355 | |
| Drug | Hymecromone | 3.22e-06 | 25 | 94 | 4 | ctd:D006923 | |
| Drug | AzMC | 3.22e-06 | 25 | 94 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 3.22e-06 | 25 | 94 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 3.22e-06 | 25 | 94 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 3.22e-06 | 25 | 94 | 4 | CID000013662 | |
| Drug | Invader | 3.48e-06 | 56 | 94 | 5 | CID006442259 | |
| Drug | glabridin | 3.76e-06 | 8 | 94 | 3 | ctd:C107601 | |
| Drug | Thymol | 3.80e-06 | 26 | 94 | 4 | ctd:D013943 | |
| Drug | norclozapine | 3.81e-06 | 57 | 94 | 5 | CID000002820 | |
| Drug | 3-hydroxyandrostan-17-one | 4.13e-06 | 102 | 94 | 6 | CID000000225 | |
| Drug | licochalcone A | 4.45e-06 | 27 | 94 | 4 | ctd:C070840 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 4.61e-10 | 5 | 93 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 4.61e-10 | 5 | 93 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 4.61e-10 | 5 | 93 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 3.21e-09 | 7 | 93 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 6.41e-09 | 8 | 93 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.15e-08 | 9 | 93 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.15e-08 | 9 | 93 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.15e-08 | 9 | 93 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.15e-08 | 9 | 93 | 4 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.15e-08 | 9 | 93 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.15e-08 | 9 | 93 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.15e-08 | 9 | 93 | 4 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.15e-08 | 9 | 93 | 4 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.15e-08 | 9 | 93 | 4 | EFO_0020691 | |
| Disease | X-21448 measurement | 1.91e-08 | 10 | 93 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.91e-08 | 10 | 93 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.91e-08 | 10 | 93 | 4 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 1.91e-08 | 10 | 93 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 3.00e-08 | 11 | 93 | 4 | EFO_0800825 | |
| Disease | pregnenetriol sulfate measurement | 3.00e-08 | 11 | 93 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 3.00e-08 | 11 | 93 | 4 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 3.00e-08 | 11 | 93 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 3.00e-08 | 11 | 93 | 4 | EFO_0800972 | |
| Disease | aldosterone measurement | 3.00e-08 | 11 | 93 | 4 | EFO_0010219 | |
| Disease | blood 4-oxo-retinoic acid measurement | 3.03e-08 | 3 | 93 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 3.03e-08 | 3 | 93 | 3 | EFO_0800043 | |
| Disease | xanthurenate measurement | 3.12e-08 | 29 | 93 | 5 | EFO_0010551 | |
| Disease | biliverdin measurement | 4.49e-08 | 12 | 93 | 4 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 4.49e-08 | 12 | 93 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 6.47e-08 | 13 | 93 | 4 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 6.47e-08 | 13 | 93 | 4 | EFO_0800587 | |
| Disease | X-21441 measurement | 2.13e-07 | 17 | 93 | 4 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.13e-07 | 17 | 93 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 2.74e-07 | 18 | 93 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 5.31e-07 | 21 | 93 | 4 | EFO_0010623 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 6.02e-07 | 6 | 93 | 3 | EFO_0800566 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.79e-06 | 28 | 93 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | response to dolutegravir | 2.38e-06 | 30 | 93 | 4 | EFO_0600017 | |
| Disease | indoleacetate measurement | 3.58e-06 | 10 | 93 | 3 | EFO_0021015 | |
| Disease | Schizophrenia | SETD1A HTR5A MYO9B DDO GRM3 SLC1A6 SLC6A12 SLC18A1 SLC18A2 PDIK1L ERVK-8 TNFRSF1B SLC23A3 | 4.03e-06 | 883 | 93 | 13 | C0036341 |
| Disease | vitamin D deficiency | 5.64e-06 | 37 | 93 | 4 | EFO_0003762 | |
| Disease | X-24588 measurement | 8.47e-06 | 13 | 93 | 3 | EFO_0800898 | |
| Disease | bilirubin measurement | 1.11e-05 | 442 | 93 | 9 | EFO_0004570 | |
| Disease | vitamin D measurement, COVID-19 | 1.76e-05 | 49 | 93 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | gallstones | 2.41e-05 | 108 | 93 | 5 | EFO_0004210 | |
| Disease | cocaine abuse (implicated_via_orthology) | 2.94e-05 | 3 | 93 | 2 | DOID:809 (implicated_via_orthology) | |
| Disease | urate measurement, spine bone mineral density | 3.44e-05 | 58 | 93 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | tartronate (hydroxymalonate) measurement | 5.87e-05 | 4 | 93 | 2 | EFO_0800944 | |
| Disease | metabolite measurement | SETD1A SLC17A3 GLB1L3 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC6A12 G6PD | 7.01e-05 | 560 | 93 | 9 | EFO_0004725 |
| Disease | thyroxine measurement | 1.40e-04 | 83 | 93 | 4 | EFO_0005130 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 1.46e-04 | 6 | 93 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | hormone measurement | 1.47e-04 | 84 | 93 | 4 | EFO_0004730 | |
| Disease | cholelithiasis | 1.76e-04 | 88 | 93 | 4 | EFO_0004799 | |
| Disease | immature platelet count | 3.59e-04 | 106 | 93 | 4 | EFO_0803544 | |
| Disease | threonate measurement | 4.35e-04 | 10 | 93 | 2 | EFO_0021032 | |
| Disease | urinary bladder carcinoma | 4.44e-04 | 47 | 93 | 3 | MONDO_0004986 | |
| Disease | hemolysis | 4.44e-04 | 47 | 93 | 3 | EFO_0009473 | |
| Disease | immature platelet fraction | 4.73e-04 | 114 | 93 | 4 | EFO_0009187 | |
| Disease | dodecanedioate measurement | 6.35e-04 | 12 | 93 | 2 | EFO_0021054 | |
| Disease | platelet component distribution width | 6.36e-04 | 755 | 93 | 9 | EFO_0007984 | |
| Disease | ascorbic acid 3-sulfate measurement | 8.72e-04 | 14 | 93 | 2 | EFO_0800173 | |
| Disease | glycerate measurement | 1.00e-03 | 15 | 93 | 2 | EFO_0021029 | |
| Disease | vitamin C measurement | 1.15e-03 | 16 | 93 | 2 | EFO_0600003 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.22e-03 | 147 | 93 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | muscular dystrophy (is_implicated_in) | 1.30e-03 | 17 | 93 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | temporal horn of lateral ventricle volume measurement | 1.54e-03 | 72 | 93 | 3 | EFO_0010333 | |
| Disease | reticulocyte count | MYO9B PIEZO1 RMI2 EXOSC3 DNAAF9 ITGAD PRPF8 MAP3K1 NT5DC2 SLC23A1 | 1.68e-03 | 1045 | 93 | 10 | EFO_0007986 |
| Disease | Arthrogryposis | 1.98e-03 | 21 | 93 | 2 | C0003886 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVENVEWRVLGMPAR | 196 | Q9GZZ6 | |
| GFPRRAVMQVFTEWL | 606 | Q6PJG6 | |
| LVRAREGVWIPVSMD | 426 | O71037 | |
| LVRAREGVWIPVSMD | 426 | Q902F8 | |
| RDWMLAVLAFPVGVF | 86 | Q9NVV5 | |
| VIQNLFEGMIWFLVP | 231 | Q92903 | |
| LAMIVGIFALCWLPV | 236 | P29275 | |
| PLMLIAGIVICAFWV | 146 | P27037 | |
| VMVSVWLILEAPGTR | 701 | Q14832 | |
| AFLWVVVAVAMAPLL | 181 | Q13304 | |
| TLWALVFLGILVGMV | 21 | P10767 | |
| RAVTPEMRALVVDWL | 101 | Q9H8S5 | |
| VGRLFMWEEPEIQAA | 151 | Q9Y235 | |
| QVPMARASILWLIGE | 496 | Q13367 | |
| PVVLTVAMAGLVVWR | 126 | O60896 | |
| DMFLSVIGQRWPIDV | 56 | Q5QFB9 | |
| RAFTMLGVVWLVAVI | 161 | Q96P65 | |
| LMVLRFANRIFGPIW | 211 | P11413 | |
| IPVDTVVNLMLAVGW | 276 | Q96K12 | |
| IVVWPMLRPDIFTGL | 416 | Q6PIW4 | |
| LLSALPFIVAWVIGM | 256 | O00476 | |
| FVVLIGWPLIGMIFE | 76 | Q9Y3E0 | |
| RGRVVMLIVGVWVAA | 141 | Q9HBW0 | |
| QCIRFPVVAMGVLKW | 416 | Q8IXH7 | |
| VLVVMVVAFAVLWLP | 266 | P50391 | |
| FVLMAAEIGLWVILR | 146 | Q8NCI6 | |
| PRVIWYRGGLEMILA | 726 | Q8NDA2 | |
| IVFGMVLFLWEHVPA | 301 | Q8N3F9 | |
| MEPIRWLLAAAGVEF | 16 | Q16772 | |
| RQPVMVLVGGLEFWL | 1191 | P51805 | |
| VHPEWRRAGIATFMI | 706 | Q9H8E8 | |
| LVWAIAIFMGAVPTL | 151 | Q9UBY5 | |
| LVRAREGVWIPVSMD | 1186 | P63135 | |
| VPFWADVVLGFRKMT | 106 | Q99489 | |
| VVGVPANAVTLWMLF | 106 | O00254 | |
| PVLLNGVAVWDVVME | 971 | Q13349 | |
| KDWMRPIVIAIFVGV | 831 | O15118 | |
| MWGFLKRPVVVTADI | 1 | Q9Y6A1 | |
| FGRWMDVVVDDRLPV | 146 | Q6ZSI9 | |
| PVLMLYRLWEEGIVA | 86 | A8MY62 | |
| PGILRWFEVKSVFMV | 1471 | Q14185 | |
| LVRAREGVWIPVSMD | 426 | P61570 | |
| LVRAREGVWIPVSMD | 426 | Q69384 | |
| IFRMLVLGVAAEDVW | 31 | P57773 | |
| LMSVPEIRAVVDAWA | 141 | P07902 | |
| VLVTAGPVFTEEMWR | 1591 | Q5TH69 | |
| FRVMILVVAAQEVWG | 31 | O95452 | |
| LMVQICVWFGRPLEK | 971 | Q5TEA3 | |
| MVGILIGVFVLCWIP | 286 | P47898 | |
| EAIMRLVGIIIWYAP | 301 | P48664 | |
| GRVWLSVIFIFRIMV | 21 | P08034 | |
| FRIMVLVVAAESVWG | 31 | P08034 | |
| LVPVLGSRWLMVNVA | 86 | Q9BSK0 | |
| PREMTRWVRGIFEAL | 2796 | Q14204 | |
| TILVVLGAFMVTWGP | 271 | Q8N6U8 | |
| VLMAAEIGLWVILRP | 121 | Q8IW92 | |
| LVRAREGVWIPVSMD | 426 | Q902F9 | |
| PVAIVMLRAIRDFFW | 231 | Q9Y315 | |
| ARMPVQIRVKLWFGL | 846 | O75923 | |
| PLEIVFGMNGRIWVK | 226 | Q9NQT5 | |
| FLVEESEPVVWRGLM | 146 | Q8TB37 | |
| EWVIFIMGGLILVIP | 196 | P30953 | |
| LAEPWIQVFGMELVG | 556 | Q13233 | |
| LWDIIFMDGIPDVFR | 846 | Q9Y2M0 | |
| AAERWFILQMEVGEP | 1196 | Q8NET4 | |
| LMPEPAQRWLVGFVL | 211 | P30872 | |
| GPLDLAAVWMQGRVV | 51 | Q96E14 | |
| NWDPVMVGIRRIFAF | 476 | Q8WV83 | |
| LSPRMLVWLVASGIV | 6 | O43897 | |
| AIADLGIVLSLPVWM | 96 | O15218 | |
| FALGIIIWAMLERIT | 241 | Q8N165 | |
| SPVMEFWERRVLGIT | 186 | P48065 | |
| FLLNPWTAGIIVMVL | 1046 | Q13635 | |
| PIVLFLGRSVMQDFW | 311 | A6NNN8 | |
| PATGRWRMLLIVVSV | 26 | Q8N9A8 | |
| RIHEWGLFAMEPIAA | 1576 | O15047 | |
| IVGFSIFMALLLPRW | 456 | Q6PIS1 | |
| WVLDFGRPIAMLVFP | 56 | Q9NWW5 | |
| VAAIAMARIIDLVPW | 51 | Q6URK8 | |
| VWLFFMRGITPLLER | 636 | Q6P2Q9 | |
| RWLPVLMVVIAAALA | 526 | Q9Y228 | |
| DIFALGIIIWAMIER | 436 | Q8TDR2 | |
| LDPVWLFVVVGGVMS | 61 | Q96FV3 | |
| PLDLAVFWVEFVMRH | 451 | Q9HAW8 | |
| DARGDIMAIAPWIRI | 291 | Q9UHI7 | |
| VVMLSGFWVVLARGV | 196 | Q92911 | |
| VEIMPEWVFVGLVLL | 181 | Q71H61 | |
| MCFEIPPRWLDLTVV | 496 | Q5TEJ8 | |
| WSIRTALLAIIGFMP | 106 | Q9Y385 | |
| VLVVMVVAFAVLWLP | 266 | P0DQD5 | |
| HMVGPDWRQLFDVVI | 281 | Q9H857 | |
| PLDLAVFWVEFVMRH | 451 | O60656 | |
| CILGEWLPILIMAVF | 381 | Q7RTT9 | |
| MAPVAVWAALAVGLE | 1 | P20333 | |
| LVPFLVELRAVMDWV | 2111 | Q92508 | |
| FWIRVQESVMVPEGL | 21 | Q96LC7 | |
| AIGFPWLMTIIGIID | 446 | Q05940 | |
| WLMTIIGIIDILFAP | 451 | Q05940 | |
| PLDLAVFWVEFVMRH | 451 | Q9HAW7 | |
| PLDLAVFWVEFVMRH | 451 | Q9HAW9 | |
| GFPWLMVITGVINIV | 456 | P54219 | |
| LVIWNVILRFMGDLP | 1011 | Q6PIF6 | |
| MIGIDPVAVFRWAIL | 691 | B2RTY4 | |
| VRELIGMDPVAVFRW | 671 | Q13459 | |
| GMDPVAVFRWAVLRA | 676 | Q13459 |